Item 8.01. Other Events.

On January 11, 2022, Applied Genetic Technologies Corporation issued a press release announcing updated information regarding its ongoing X-linked retinitis pigmentosa (XLRP) clinical trials. A copy of this press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
  No.       Description

99.1          Press release dated January 11, 2022.

104         The cover page from this Current Report on Form 8-K, formatted in
            Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses